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INTRODUCTION
Sedation can be defined as a pharmacologically induced 
state of a reduced level of consciousness. According to recent 
nation-wide surveys, the majority of endoscopic procedures 
are currently performed under sedation.1,2 Drugs used for en-
doscopic sedation vary between centers, as some may use a 
single agent or mix two sedatives, such as propofol and mid-
azolam, while others may combine a sedative with an analge-
sic.1-3 The administration of sedatives and analgesics increase 
the patient’s tolerance to discomfort or pain, and therefore im-
prove the outcomes of diagnostic or therapeutic endoscopic 
procedures.3-5 A patient under an appropriate depth of seda-
tion should feel comfortable and be able to cooperate with the 
endoscopist, while being able to maintain his or her airway 
reflexes and a stable state of spontaneous respiration. This usu-
ally corresponds to the level of ‘moderate sedation’ among 
the depths of sedation defined by the American Society of An-
esthesiologists (ASA), as seen in Table 1.6 Although sedatives 
and analgesics suppress the central nervous system in a dose-
dependent manner, patients tend to differ considerably in their 
responses to different drugs, and therefore, the depth of seda-
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tion can be altered rapidly on a continuum of minimal seda-
tion and general anesthesia. An unintended deep level of se-
dation may cause depressed respiratory and cardiovascular 
function, which may be fatal in certain patients. Serious car-
diorespiratory complications are known to occur in 0.54% of 
endoscopic procedures performed under sedation,7 and a mor-
tality rate as high as 0.05% has been reported.8 The patient 
scheduled for endoscopic procedures under sedation should 
therefore be carefully evaluated for any medical history and 
current medical status and closely monitored for any changes 
in respiratory and cardiovascular instabilities.
PRESEDATION EVALUATION
Because many drugs that are used for sedation and analgesia 
have a narrow margin of safety, with patients often presenting 
with different reactions to the same dose of the same drug, 
careful presedation evaluation is necessary.
Past medical history and current status
Serious complications that can occur during sedation are 
due to either hypoxemia caused by respiratory depression or 
hypotension and arrhythmia caused by cardiovascular col-
lapse. Therefore, irrespective of whether the patient has any 
underlying cardiac or pulmonary disease, and the severity of 
such comorbidities should always be evaluated. Moreover, 
any kidney or liver disease that may alter the half-life of certain 
drugs or increase the effect of sedative metabolites, such as 
midazolam, should be evaluated.9 Sedatives and analgesics 
should be chosen based on any possible interactions they may 
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have with current medications of the patient and a history of 
drug allergies. Patients who have previously received seda-
tion or general anesthesia should be evaluated for any history 
of adverse reactions to sedatives or anesthetics and a history 
of difficult airway management. It should be noted that obese 
patients or those with obstructive sleep apnea may present 
with airway obstruction and hypoxia even in the absence of 
respiratory suppression.10 Further, the ASA physical status 
should be documented in every patient, as the risk of serious 
cardiopulmonary complications is significantly increased in 
those with an ASA physical status of III or higher.11
Airway evaluation
Because all sedatives have the potential to cause respiratory 
depression, and thus require emergency tracheal intubation, 
airway evaluation should be assessed by measuring Mallam-
pati scores and chin-hyoid distance (Fig. 1).12 Patients with a 
high Mallampati score, a chin-hyoid distance under 4 cm, or 
a history of difficult intubation, are all at risk of difficult airway 
management, and should be carefully managed so as not to 
fall into unintended deep sedation.
Presedation fasting
Decreased airway reflexes during sedation will render a 
patient more susceptible to aspiration. In order to prevent as-
piration during sedation, an appropriate fasting time should 
be maintained as follows: at least 2 hours for water, pulp-free 
juice, and tea or coffee without milk, and at least 6 hours for 
solid foods, including milk. However, obese patients and those 
with gastroesophageal reflux or diabetes should consider main-
taining a longer fasting time.13
MONITORING
When an unintended level of deep sedation is reached dur-
ing an endoscopic procedure, respiratory depression or hypo-
tension may occur. In order to prevent and properly manage 
such an event, the depth of sedation and cardiorespiratory signs 
should be periodically and continuously monitored in all pa-
tients. It is of utmost importance that continuous monitoring 
be carried out by qualified medical personnel other than the 
endoscopist.
Hemodynamic monitoring
Continuous monitoring of heart rate and blood pressure is 
essential during sedation, and should be checked and record-
ed at least every 5 minutes, starting before the administration 
of sedatives.14 Hypertension and tachycardia may occur when 
an appropriate depth of sedation for the procedure is not 
reached, while hypotension and bradycardia is often observed 
during oversedation. However, changes in blood pressure and 
heart rate can vary largely between patients, and close observa-
tion for pain and vasovagal reflexes that may affect vital signs 
is needed.
Pulse oximetry and respiratory rate
Because virtually every sedative is capable of suppressing 
the central respiratory drive, pulse oximetry monitoring and 
oxygen supplementation is of the essence during endoscopic 
sedation.15,16 However, pulse oximetry measures arterial oxy-
gen saturation, not alveolar ventilation, and therefore does not 
immediately reflect respiratory depression. It should be kept 
in mind that pulse oximetry will not fall before alveolar oxy-
gen partial pressure is first decreased in a patient that is receiv-
ing oxygen supplementation. In such cases, pulse oximetry 
will be overestimated, even in the setting of significant alveolar 
hypoventilation.16,17 Capnography is a noninvasive method 
that can monitor the carbon dioxide concentration during ex-
piration. Although this is not currently recommended as part 
of routine monitoring during endoscopic sedation, it may be 
helpful in patients at high risk for respiratory depression or 
those requiring deep sedation.18
Oxygen supplementation and equipment
Providing supplementary oxygen to a patient before respira-
tory depression occurs is very important for maintaining pa-
Table 1. American Society of Anesthesiologists Classification for Sedation and Analgesia
Minimal sedation Moderate sedation Deep sedation General anesthesia
Responsiveness Normal response to 
  verbal stimulation
Purposeful response to 
  verbal or tactile stimulation
Purposeful response to 
  repeated or painful stimuli
Unarousable, even with 
  painful stimulus
Airway Unaffected No intervention required Intervention may be required Intervention often required
Spontaneous 
  ventilation
Unaffected Adequate May be inadequate Frequently inadequate
Cardiovascular 
  function
Unaffected Usually maintained Usually maintained May be impaired
Adapted from American Society of Anesthesiologists Task Force on Sedation and Analgesia by Non-Anesthesiologists. Anesthesiology 2002; 
96:1004-1017, with permission from American Society of Anesthesiologists.6
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tient safety during sedation. Because most drugs used for en-
doscopic sedation are short-acting, most episodes of respiratory 
depression do not exceed several minutes, and external stim-
ulations such as the insertion of the endoscope are required for 
patients to recover from them.19 As mentioned earlier, achiev-
ing a significant increase in arterial oxygen partial pressure by 
supplying oxygen to the patient will help maintain arterial ox-
ygen saturation in the setting of transient alveolar hypoventi-
lation. Closely monitoring the patient for signs of respiratory 
depression, such as decreased respiratory rate, and prompt 
management of such events can prevent significant hypoxemia 
during sedation. Other than oxygen supply, aspirators, face 
masks, oral and nasal airways, reservoir bags, laryngoscopes, 
and endotracheal tubes, drugs for cardiopulmonary resuscita-
tion and antidotes to sedatives and opioids, such as naloxone 
and flumazenil, should always be prepared in the sedation 
unit regardless of the type of procedure being carried out.
Monitoring during recovery and discharge
Even after the endoscopic procedure is finished, the patient 
may still be at risk of cardiopulmonary complications, depend-
ing on the duration of sedatives or analgesics used for sedation 
and the general condition of the patient. The cessation of ex-
ternal stimulation from the endoscopic procedure may cause 
an unexpected fall in blood pressure or heart rate. Therefore, 
patients should be monitored for changes in vital signs and 
mental status by qualified staff members after the procedure 
until the patient is fully awake and able to maintain stable vital 
Table 2. Modified Aldrete Score
Parameter Description of patient Score
Activity Able to move four extremities voluntarily or on command 2
Able to move two extremities voluntarily or on command 1
Unable to move extremities voluntarily or on command 0
Respiration Able to breathe deeply and cough freely 2
Dyspnea or limited breathing 1
Apneic 0
Circulation Blood pressure+20% of preanesthetic level 2
Blood pressure+20% to 49% of preanesthetic level 1
Blood pressure+50% of preanesthetic level 0
Conciousness Fully awake 2
Arousable on calling 1
Not responding 0
O2 saturation Able to maintain O2 saturation >92% on room air 2
Needs O2 inhalation to maintain O2 saturation >90% 1
O2 saturation <90% even with O2 supplement 0
Adapted from Aldrete JA. J Perianesth Nurs 1998;13:148-155, with permission from Elsevier.19
Soft palate, uvula, and
pillars are visible
I II III IV
Soft palate and base of
the uvula are visible
Only soft palate is
visible
Only hard palate is
visible
Fig. 1. Mallampati classification system.
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signs. Although there is not a standardized guideline for post-
procedure monitoring, the estimated duration of effect for 
the sedatives that were used and the general condition of the 
patient should be taken into consideration before discharge. 
Postprocedure monitoring should include blood pressure and 
pulse oximetry, which should be continued until discharge. 
Among the various scoring systems for the assessment of re-
covery, the Aldrete scale is most commonly used.20 The Al-
drete scale consists of a scoring system for respiration, oxygen 
saturation, blood pressure, consciousness, and activity, which 
are each graded with a score of 0 to 2 (Table 2). A patient pre-
senting with a score of 8 or higher, including a score of 2 for 
respiration, is considered fit for discharge to the general ward. 
However, the patient should also be able to walk without as-
sistance, drink fluids, be free of excessive pain or nausea, and 
have an adult caregiver that is able to escort the patient home 
when they are directly discharged from the hospital. Patients 
should also be provided with written instructions explaining 
the possible complications and who to contact if needed.21
CONCLUSIONS
For an endoscopic sedation to be successful, the patient 
should be able to undergo the procedure safely and comfort-
ably. This requires careful and meticulous monitoring, indi-
vidually tailored administration of sedatives and analgesics, 
thorough preparation for emergency situations, and well-
trained professional staff members. Under the current circum-
stances of the medical community, it is difficult to have board-
certified anesthesiologists involved in all sedation procedures 
outside of the operating theater. Nonanesthesiologists that 
are performing sedation for endoscopic procedures should 
be well-informed and trained in the use of sedatives, analgesics 
and their antidotes, basic patient monitoring, airway manage-
ment techniques, and cardiopulmonary resuscitation in or-
der to provide safe and successful sedation to patients.
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